FDA issued a Study May Proceed letter for BriaCell’s Bria-PROS+ in prostate cancer. No human efficacy data yet. Full context here:
aktiego.com/sectors/biot...
Not financial advice. DYOR.
#FDA #Oncology
FDA issued a Study May Proceed letter for BriaCell’s Bria-PROS+ in prostate cancer. No human efficacy data yet. Full context here: aktiego.com/sectors/biot... Not financial advice. DYOR. #FDA #Oncology
0 views
Published on 19/08/2026 19:40
FDA issued a Study May Proceed letter for BriaCell’s Bria-PROS+ in prostate cancer. No human efficacy data yet. Full context here:
aktiego.com/sectors/biot...
Not financial advice. DYOR.
#FDA #Oncology
0 comments
?